On this page of StockholderLetter.com we present the latest annual shareholder letter from Walgreens Boots Alliance, Inc. — ticker symbol WBA. Reading current and past WBA letters to shareholders can bring important insights into the investment thesis.
2024 Annual Report
2024 Board of Directors As of August 31, 2024 From left to right, sitting then standing Inderpal S. Bhandari Janice M. Babiak Stefano Pessina Former Global Chief Data Officer, International Business Machines Corporation Former Managing Partner, Ernst & Young LLP Executive Chairman, Walgreens Boots Alliance, Inc. Bryan C. Hanson John A. Lederer Chief Executive Officer, Solventum Corporation Senior Advisor, Sycamore Partners Ginger L. Graham Lead Independent Director, Walgreens Boots Alliance, Inc. Former President and Chief Executive Officer, Amylin Pharmaceuticals Valerie B. Jarrett Chief Executive Officer, The Barack Obama Foundation Thomas E. Polen Chairman, President and Chief Executive Officer, Becton, Dickinson and Company (BD) Robert L. Hu nes Former Global Chairman, Investment Banking at J.P. Morgan Chase & Co. Timothy C. Wentworth Chief Executive Officer, Walgreens Boots Alliance, Inc. William H. Shrank, M.D. Venture Partner, Andreessen Horowitz, Bio+Health Team Nancy M. Schlichting Former Chief Executive Officer, Henry Ford Health System
 • shareholder letter icon 12/13/2024 Letter Continued (Full PDF)
 • stockholder letter icon 12/8/2023 WBA Stockholder Letter
 • stockholder letter icon More "Grocery & Drug Stores" Category Stockholder Letters
 • Benford's Law Stocks icon WBA Benford's Law Stock Score = 68


WBA Shareholder/Stockholder Letter Transcript:

2024
Annual
Report

2024
Board of Directors
As of August 31, 2024
From left to right, sitting then standing
Inderpal S. Bhandari
Janice M. Babiak
Stefano Pessina
Former Global Chief Data Officer,
International Business Machines
Corporation
Former Managing Partner,
Ernst & Young LLP
Executive Chairman,
Walgreens Boots Alliance, Inc.
Bryan C. Hanson
John A. Lederer
Chief Executive Officer,
Solventum Corporation
Senior Advisor, Sycamore Partners
Ginger L. Graham
Lead Independent Director,
Walgreens Boots Alliance, Inc.
Former President and Chief Executive
Officer, Amylin Pharmaceuticals
Valerie B. Jarrett
Chief Executive Officer,
The Barack Obama Foundation
Thomas E. Polen
Chairman, President and Chief
Executive Officer, Becton, Dickinson and
Company (BD)
Robert L. Hu   nes
Former Global Chairman, Investment
Banking at J.P. Morgan Chase & Co.
Timothy C. Wentworth
Chief Executive Officer,
Walgreens Boots Alliance, Inc.
William H. Shrank, M.D.
Venture Partner, Andreessen Horowitz,
Bio+Health Team
Nancy M. Schlichting
Former Chief Executive Officer,
Henry Ford Health System



shareholder letter icon 12/13/2024 Letter Continued (Full PDF)
 

WBA Stockholder/Shareholder Letter (Walgreens Boots Alliance, Inc.) | www.StockholderLetter.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.